Rights and permissions
About this article
Cite this article
Simvastatin a winner regardless of vascular risk level. Pharmacoecon. Outcomes News 479, 5 (2005). https://doi.org/10.2165/00151234-200504790-00013
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504790-00013